Concepts (153)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Femoracetabular Impingement | 8 | 2025 | 12 | 3.050 |
Why?
|
| Ketamine | 6 | 2023 | 225 | 1.760 |
Why?
|
| Hip Joint | 8 | 2025 | 46 | 1.320 |
Why?
|
| Osteoarthritis, Hip | 4 | 2025 | 61 | 1.300 |
Why?
|
| Depressive Disorder, Treatment-Resistant | 4 | 2023 | 128 | 1.160 |
Why?
|
| Arthroscopy | 5 | 2024 | 45 | 1.040 |
Why?
|
| Transcranial Magnetic Stimulation | 2 | 2023 | 80 | 0.970 |
Why?
|
| Physical Therapy Modalities | 3 | 2024 | 57 | 0.780 |
Why?
|
| Orthopedics | 1 | 2023 | 78 | 0.750 |
Why?
|
| Depressive Disorder, Major | 3 | 2022 | 461 | 0.740 |
Why?
|
| Fractures, Bone | 1 | 2023 | 206 | 0.680 |
Why?
|
| Neuroprotective Agents | 1 | 2020 | 161 | 0.610 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2021 | 111 | 0.610 |
Why?
|
| Hearing Disorders | 3 | 2023 | 29 | 0.610 |
Why?
|
| Anxiety Disorders | 3 | 2023 | 734 | 0.600 |
Why?
|
| Australia | 7 | 2025 | 185 | 0.570 |
Why?
|
| Anxiety | 1 | 2023 | 1002 | 0.520 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 3 | 2022 | 149 | 0.490 |
Why?
|
| Treatment Outcome | 15 | 2025 | 13016 | 0.410 |
Why?
|
| Quality of Life | 7 | 2023 | 2151 | 0.380 |
Why?
|
| Physical Therapists | 2 | 2022 | 7 | 0.380 |
Why?
|
| Suicide | 2 | 2025 | 203 | 0.360 |
Why?
|
| Tissue and Organ Procurement | 2 | 2024 | 247 | 0.330 |
Why?
|
| Biomechanical Phenomena | 4 | 2025 | 261 | 0.310 |
Why?
|
| Veterans | 1 | 2020 | 1762 | 0.300 |
Why?
|
| Humans | 35 | 2025 | 132336 | 0.300 |
Why?
|
| Osteoarthritis, Knee | 2 | 2022 | 273 | 0.290 |
Why?
|
| Exercise Therapy | 3 | 2025 | 184 | 0.280 |
Why?
|
| Walking | 3 | 2025 | 232 | 0.280 |
Why?
|
| Depression | 4 | 2023 | 1351 | 0.250 |
Why?
|
| Antidepressive Agents | 3 | 2023 | 327 | 0.240 |
Why?
|
| Perches | 1 | 2025 | 1 | 0.230 |
Why?
|
| Otolithic Membrane | 1 | 2025 | 9 | 0.230 |
Why?
|
| Fishes | 1 | 2025 | 37 | 0.230 |
Why?
|
| Resistance Training | 1 | 2025 | 32 | 0.220 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2024 | 1247 | 0.220 |
Why?
|
| Genetics, Population | 1 | 2025 | 188 | 0.210 |
Why?
|
| Methemoglobinemia | 1 | 2023 | 9 | 0.210 |
Why?
|
| Tissue Donors | 2 | 2024 | 508 | 0.210 |
Why?
|
| Exercise | 3 | 2025 | 865 | 0.210 |
Why?
|
| Borneo | 1 | 2023 | 1 | 0.200 |
Why?
|
| Transcranial Direct Current Stimulation | 1 | 2023 | 21 | 0.200 |
Why?
|
| Female | 16 | 2025 | 70788 | 0.190 |
Why?
|
| Extremities | 1 | 2023 | 87 | 0.190 |
Why?
|
| Electroencephalography | 3 | 2023 | 906 | 0.190 |
Why?
|
| Mood Disorders | 1 | 2023 | 129 | 0.180 |
Why?
|
| Organ Transplantation | 1 | 2024 | 181 | 0.180 |
Why?
|
| Acetabulum | 1 | 2021 | 18 | 0.180 |
Why?
|
| Wounds and Injuries | 1 | 2025 | 392 | 0.180 |
Why?
|
| Male | 15 | 2025 | 65054 | 0.180 |
Why?
|
| Kynurenic Acid | 1 | 2020 | 8 | 0.170 |
Why?
|
| Quinolinic Acid | 1 | 2020 | 11 | 0.170 |
Why?
|
| Parkinson Disease | 2 | 2018 | 736 | 0.170 |
Why?
|
| Adult | 10 | 2025 | 31618 | 0.170 |
Why?
|
| Emotions | 1 | 2023 | 367 | 0.170 |
Why?
|
| Kynurenine | 1 | 2020 | 26 | 0.170 |
Why?
|
| Torso | 1 | 2020 | 13 | 0.170 |
Why?
|
| Brain | 4 | 2023 | 3197 | 0.170 |
Why?
|
| Pelvis | 1 | 2020 | 72 | 0.160 |
Why?
|
| Family | 1 | 2023 | 595 | 0.160 |
Why?
|
| Age of Onset | 1 | 2021 | 626 | 0.160 |
Why?
|
| Cross-Over Studies | 1 | 2020 | 328 | 0.160 |
Why?
|
| Precision Medicine | 1 | 2023 | 361 | 0.150 |
Why?
|
| Lower Extremity | 1 | 2020 | 188 | 0.150 |
Why?
|
| Occipital Lobe | 1 | 2018 | 34 | 0.140 |
Why?
|
| Muscle, Skeletal | 1 | 2025 | 1042 | 0.140 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2019 | 100 | 0.140 |
Why?
|
| Hallucinations | 1 | 2018 | 28 | 0.140 |
Why?
|
| Lewy Body Disease | 1 | 2018 | 21 | 0.140 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2018 | 171 | 0.130 |
Why?
|
| Emergency Service, Hospital | 1 | 2025 | 1161 | 0.130 |
Why?
|
| Pain Measurement | 3 | 2025 | 351 | 0.130 |
Why?
|
| Single-Blind Method | 1 | 2017 | 247 | 0.130 |
Why?
|
| Biomarkers | 2 | 2023 | 3389 | 0.130 |
Why?
|
| Physicians | 1 | 2023 | 635 | 0.130 |
Why?
|
| Pandemics | 2 | 2023 | 1188 | 0.120 |
Why?
|
| Infusions, Intravenous | 3 | 2022 | 558 | 0.120 |
Why?
|
| Liver Transplantation | 1 | 2023 | 1103 | 0.110 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 379 | 0.110 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 390 | 0.110 |
Why?
|
| Adolescent | 5 | 2023 | 20552 | 0.110 |
Why?
|
| Child | 6 | 2023 | 25823 | 0.110 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2021 | 651 | 0.110 |
Why?
|
| Cohort Studies | 1 | 2022 | 5150 | 0.100 |
Why?
|
| Prognosis | 1 | 2022 | 5009 | 0.100 |
Why?
|
| Canada | 2 | 2024 | 343 | 0.100 |
Why?
|
| Cognition | 1 | 2018 | 814 | 0.100 |
Why?
|
| Range of Motion, Articular | 2 | 2024 | 81 | 0.090 |
Why?
|
| Retrospective Studies | 4 | 2022 | 17363 | 0.090 |
Why?
|
| Alzheimer Disease | 1 | 2018 | 865 | 0.080 |
Why?
|
| Young Adult | 2 | 2021 | 9945 | 0.080 |
Why?
|
| Bayes Theorem | 2 | 2021 | 309 | 0.080 |
Why?
|
| Infant, Newborn | 1 | 2023 | 8566 | 0.080 |
Why?
|
| Psychometrics | 2 | 2023 | 693 | 0.080 |
Why?
|
| Pain | 2 | 2022 | 461 | 0.070 |
Why?
|
| Syndrome | 2 | 2022 | 1171 | 0.070 |
Why?
|
| Middle Aged | 6 | 2025 | 28888 | 0.070 |
Why?
|
| Double-Blind Method | 2 | 2021 | 1647 | 0.070 |
Why?
|
| Parents | 2 | 2023 | 1076 | 0.060 |
Why?
|
| Fisheries | 1 | 2025 | 5 | 0.060 |
Why?
|
| Population Density | 1 | 2025 | 33 | 0.060 |
Why?
|
| Fresh Water | 1 | 2025 | 21 | 0.060 |
Why?
|
| Rivers | 1 | 2025 | 14 | 0.060 |
Why?
|
| Comparative Effectiveness Research | 1 | 2025 | 71 | 0.060 |
Why?
|
| Mutation | 1 | 2019 | 6248 | 0.060 |
Why?
|
| Electromyography | 1 | 2025 | 140 | 0.060 |
Why?
|
| Liver | 2 | 2023 | 1815 | 0.050 |
Why?
|
| Stakeholder Participation | 1 | 2024 | 32 | 0.050 |
Why?
|
| Ecosystem | 1 | 2025 | 106 | 0.050 |
Why?
|
| Animals | 2 | 2025 | 34989 | 0.050 |
Why?
|
| Impulsive Behavior | 1 | 2025 | 159 | 0.050 |
Why?
|
| Methemoglobin | 1 | 2023 | 5 | 0.050 |
Why?
|
| United Kingdom | 1 | 2024 | 234 | 0.050 |
Why?
|
| Suicide, Attempted | 1 | 2025 | 154 | 0.050 |
Why?
|
| Organ Preservation | 1 | 2023 | 53 | 0.050 |
Why?
|
| Family Relations | 1 | 2023 | 71 | 0.050 |
Why?
|
| Acetylcysteine | 1 | 2023 | 85 | 0.050 |
Why?
|
| Perfusion | 1 | 2023 | 209 | 0.050 |
Why?
|
| Death | 1 | 2023 | 78 | 0.050 |
Why?
|
| Brain Death | 1 | 2023 | 73 | 0.050 |
Why?
|
| Equivalence Trials as Topic | 1 | 2022 | 25 | 0.050 |
Why?
|
| Confidentiality | 1 | 2023 | 106 | 0.050 |
Why?
|
| Morbidity | 1 | 2022 | 255 | 0.050 |
Why?
|
| Arthralgia | 1 | 2022 | 68 | 0.050 |
Why?
|
| Phenethylamines | 1 | 2021 | 14 | 0.050 |
Why?
|
| Random Allocation | 1 | 2021 | 431 | 0.040 |
Why?
|
| Suicidal Ideation | 1 | 2023 | 254 | 0.040 |
Why?
|
| Adaptation, Psychological | 1 | 2023 | 455 | 0.040 |
Why?
|
| Risk Factors | 2 | 2025 | 10910 | 0.040 |
Why?
|
| Research Design | 1 | 2024 | 750 | 0.040 |
Why?
|
| Pyridines | 1 | 2021 | 248 | 0.040 |
Why?
|
| Mental Status Schedule | 1 | 2018 | 44 | 0.040 |
Why?
|
| Creatine | 1 | 2018 | 40 | 0.040 |
Why?
|
| Gray Matter | 1 | 2018 | 44 | 0.040 |
Why?
|
| Aged | 3 | 2025 | 21379 | 0.040 |
Why?
|
| Health Personnel | 1 | 2023 | 546 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2025 | 3421 | 0.030 |
Why?
|
| Health Services Accessibility | 1 | 2023 | 656 | 0.030 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2018 | 298 | 0.030 |
Why?
|
| Genomics | 1 | 2025 | 1652 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 7111 | 0.030 |
Why?
|
| Betacoronavirus | 1 | 2020 | 300 | 0.030 |
Why?
|
| White Matter | 1 | 2018 | 211 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2018 | 615 | 0.030 |
Why?
|
| Pedigree | 1 | 2019 | 1725 | 0.030 |
Why?
|
| Oxygen | 1 | 2018 | 572 | 0.030 |
Why?
|
| Visual Acuity | 1 | 2018 | 707 | 0.030 |
Why?
|
| Cognition Disorders | 1 | 2018 | 571 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2018 | 2145 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2018 | 1964 | 0.020 |
Why?
|
| Intellectual Disability | 1 | 2019 | 1093 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2018 | 6540 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2018 | 3853 | 0.020 |
Why?
|